Cargando…

Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma Center

SIMPLE SUMMARY: Age is one of many prognostic factors for overall survival in patients with skeletal osteosarcoma. This retrospective study provides an overview of survival in patients with high-grade osteosarcoma in different age groups. It shows prognostic variables for survival and local control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evenhuis, Richard E., Acem, Ibtissam, Rueten-Budde, Anja J., Karis, Diederik S. A., Fiocco, Marta, Dorleijn, Desiree M. J., Speetjens, Frank M., Anninga, Jakob, Gelderblom, Hans, van de Sande, Michiel A. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865349/ https://www.ncbi.nlm.nih.gov/pubmed/33513855 http://dx.doi.org/10.3390/cancers13030486

Ejemplares similares

Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trial
por: Hazewinkel, Audinga-Dea, et al.
Publicado: (2022)

Prediction tools for the personalized management of soft-tissue sarcomas of the extremity
por: Acem, Ibtissam, et al.
Publicado: (2022)

External validation and adaptation of a dynamic prediction model for patients with high‐grade extremity soft tissue sarcoma
por: Rueten‐Budde, Anja J., et al.
Publicado: (2020)

Dynamic prediction of overall survival: a retrospective analysis on 979 patients with Ewing sarcoma from the German registry
por: Liu, Chuchu, et al.
Publicado: (2020)

Impact of Age at Diagnosis on Cardiotoxicity in High-Grade Osteosarcoma and Ewing Sarcoma Patients
por: Heemelaar, Julius C., et al.
Publicado: (2023)

Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery
por: Bosma, S. E., et al.
Publicado: (2019)

Short-term and long-term prognostic value of histological response and intensified chemotherapy in osteosarcoma: a retrospective reanalysis of the BO06 trial
por: Musta, Eni, et al.
Publicado: (2022)

Single‐Center Experience with Ifosfamide Monotherapy as Second‐Line Treatment of Recurrent/Metastatic Osteosarcoma
por: Verschoor, Arie Jan, et al.
Publicado: (2019)

Investigating hospital heterogeneity with a competing risks frailty model
por: Rueten‐Budde, Anja J., et al.
Publicado: (2018)

Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model
por: Willeumier, Julie J, et al.
Publicado: (2017)

Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma
por: Lancia, Carlo, et al.
Publicado: (2019)

Management of Soft Tissue Sarcomas in Extremities: Variation in Treatment Recommendations and Surveillance According to Specialty and Continent
por: Acem, Ibtissam, et al.
Publicado: (2021)

Novel longitudinal Multiple Overall Toxicity (MOTox) score to quantify adverse events experienced by patients during chemotherapy treatment: a retrospective analysis of the MRC BO06 trial in osteosarcoma
por: Spreafico, Marta, et al.
Publicado: (2021)

A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup
por: Lancia, Carlo, et al.
Publicado: (2019)

ASO Author Reflections: Towards Patient-Tailored Management of Extremity Soft Tissue Sarcoma
por: Acem, I., et al.
Publicado: (2021)

The Association of Metastasis Pattern and Management of Metastatic Disease with Oncological Outcomes in Patients with Malignant Peripheral Nerve Sheath Tumors: A Multicenter Cohort Study
por: Acem, Ibtissam, et al.
Publicado: (2021)

Follow-Up after Curative Surgical Treatment of Soft-Tissue Sarcoma for Early Detection of Recurrence: Which Patients Have More or Fewer Visits than Advised in Guidelines?
por: Kruiswijk, Anouk A., et al.
Publicado: (2023)

Report from the 4th European Bone Sarcoma Networking meeting: focus on osteosarcoma
por: Strauss, Sandra J., et al.
Publicado: (2018)

Treatment Strategies for Metastatic Soft Tissue Sarcomas
por: Wiltink, Lisette M., et al.
Publicado: (2021)

Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma
por: Heemelaar, Julius C., et al.
Publicado: (2022)

Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients
por: Buddingh, Emilie P., et al.
Publicado: (2012)

Interaction of Human Complement Factor H Variants Tyr(402) and His(402) with Leptospira spp.
por: Silva, Aldacilene Souza, et al.
Publicado: (2011)

(18)F-FDG PET-CT versus MRI for detection of skeletal metastasis in Ewing sarcoma
por: Bosma, S. E., et al.
Publicado: (2019)

Health-Related Quality of Life of Bone and Soft-Tissue Tumor Patients around the Time of Diagnosis
por: Kruiswijk, Anouk A., et al.
Publicado: (2023)

402. Spontaneous pneumothorax in COVID-19
por: Tariq, Zain, et al.
Publicado: (2020)

Zinc Binding to the Tyr402 and His402 Allotypes of Complement Factor H: Possible Implications for Age-Related Macular Degeneration
por: Nan, Ruodan, et al.
Publicado: (2011)

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
por: Cleton-Jansen, A-M, et al.
Publicado: (2009)

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
por: Cleton-Jansen, A-M, et al.
Publicado: (2009)

Validation of the COVID-19 IgG/IgM Rapid Test Cassette (BNCP – 402 and BNCP402) in a South African setting
por: Mensky, Gilad, et al.
Publicado: (2022)

MD 402: Head-on limits. Separation leveling.
por: Barranco Garcia, Javier, et al.
Publicado: (2016)

Abstrich: Nr. 02 402 nicht vergessen!
por: Zimmermann, Gerd W.
Publicado: (2021)

Prognostic Significance of Immunohistochemical Markers and Genetic Alterations in Malignant Peripheral Nerve Sheath Tumors: A Systematic Review
por: Martin, Enrico, et al.
Publicado: (2020)

Osteosarcoma (Osteogenic sarcoma)
por: Picci, Piero
Publicado: (2007)

Marginal structural models with dose-delay joint-exposure for assessing variations to chemotherapy intensity
por: Lancia, Carlo, et al.
Publicado: (2018)

Short-term results of total shoulder arthroplasty for ochronotic arthritis
por: Dorleijn, Desiree, et al.
Publicado: (2019)

Osteosarcoma: Evolution of Treatment Paradigms
por: Jaffe, Norman, et al.
Publicado: (2013)

Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment
por: van Maldegem, Annemiek M, et al.
Publicado: (2012)

Sumoylation of Human Argonaute 2 at Lysine-402 Regulates Its Stability
por: Sahin, Umut, et al.
Publicado: (2014)

402. Clinical Characteristics and Outcome of Staphylococcus lugdunensis Prosthetic Joint Infections
por: Masood, Komal, et al.
Publicado: (2019)

Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma
por: Evola, Francesco R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kscl302url6reb778hreb49s7e